Meta Description: Discover Meso-Zeaxanthin — the critical macular carotenoid that protects central vision. Learn about its role in the 10:10:2 formula (Lutein:Meso-Zeaxanthin:Zeaxanthin), clinical evidence from AREDS2, and how to choose a quality Meso-Zeaxanthin supplier for your eye health supplements.
Keywords: Meso-Zeaxanthin, macular carotenoid, eye health supplement, macular pigment, AREDS2 formula, lutein zeaxanthin meso-zeaxanthin, blue light protection, AMD prevention
At the very center of your retina — in the fovea, the tiny 1.5 mm zone responsible for your sharpest, most detailed central vision — sits a golden-yellow pigment composed almost entirely of Meso-Zeaxanthin. This remarkable carotenoid, together with lutein and zeaxanthin, forms the macular pigment — your eyes' built-in "internal sunglasses" that filter harmful blue light and neutralize oxidative damage before it reaches your delicate photoreceptors. As screen time soars and the global population ages, the demand for Meso-Zeaxanthin-enriched eye health supplements is growing exponentially. This comprehensive guide covers everything you need to know about this critical nutrient.
| Attribute | Detail |
|---|---|
| Chemical Name | (3R,3'S)-β,β-Carotene-3,3'-diol |
| CAS Number | 31341-36-9 |
| Molecular Formula | C₄₀H₅₆O₂ |
| Molecular Weight | 568.88 g/mol |
| Compound Class | Xanthophyll carotenoid (oxygenated carotenoid) |
| Isomer Relationship | Meso-Zeaxanthin (3R,3'S), Zeaxanthin (3R,3'R), and Lutein (3R,3'R,6'R) are isomeric carotenoids |
The human macula contains three xanthophyll carotenoids in a precisely orchestrated spatial distribution:
| Carotenoid | Macular Zone | Concentration | Primary Food Source | Unique Feature |
|---|---|---|---|---|
| Meso-Zeaxanthin | Central fovea (0–0.5 mm) | Highest at center | Produced in the retina from lutein; essentially absent from diet | Dominant carotenoid at the point of sharpest vision |
| Zeaxanthin | Mid-peripheral macula (0.5–2 mm) | Medium | Corn, goji berries, orange peppers, egg yolk | Both dietary and retinal origin |
| Lutein | Peripheral macula (> 2 mm) | Highest in periphery | Dark leafy greens (spinach, kale), marigold flowers | Most abundant dietary carotenoid; precursor to MZ |
Unlike lutein and zeaxanthin, which are abundant in a typical diet, Meso-Zeaxanthin is virtually absent from food sources. The human body produces it endogenously by converting lutein to Meso-Zeaxanthin in the retinal pigment epithelium (RPE) via the enzyme RPE65 (also known as the isomerohydrolase). However, this conversion efficiency declines with age, and many individuals — particularly those over 40 — cannot produce sufficient Meso-Zeaxanthin to maintain optimal macular pigment density.
This is where supplementation becomes essential.
GreenskyBio Meso-Zeaxanthin — Available Forms:
| Form | Meso-Zeaxanthin Content | Carrier/Matrix | Primary Application |
|---|---|---|---|
| Oil Suspension | 5–10% | MCT oil or sunflower oil | Softgel capsules |
| Microencapsulated Powder | 5–10% | Modified starch / gelatin | Hard capsules, tablets |
| Water-Dispersible Powder | 2–5% | Gum arabic | Functional beverages |
| High-Purity | 20–30% | Minimal excipients | Premium formulations |
Quality Specifications (10% Oil Suspension Grade):
Meso-Zeaxanthin: ≥ 10.0% (HPLC)
Total Carotenoids: ≥ 15.0%
Cis-isomers: ≤ 5.0%
Moisture: ≤ 3.0%
Peroxide Value: ≤ 5.0 meq/kg
Anisidine Value: ≤ 10.0
TOTOX Value: ≤ 20.0
| Test Parameter | Specification | Result | Method |
|---|---|---|---|
| Meso-Zeaxanthin | ≥ 10.0% | 10.42% | HPLC-UV (450 nm) |
| Total Carotenoids | ≥ 15.0% | 16.81% | Spectrophotometry |
| Cis-Isomers | ≤ 5.0% | 3.1% | HPLC |
| Moisture | ≤ 3.0% | 1.8% | Karl Fischer |
| Peroxide Value | ≤ 5.0 meq/kg | 2.4 meq/kg | AOCS Cd 8b-90 |
| Anisidine Value | ≤ 10.0 | 4.6 | AOCS Cd 18-90 |
| TOTOX (2×PV + AV) | ≤ 20.0 | 9.4 | Calculation |
| Heavy Metals (Pb) | ≤ 1.0 mg/kg | 0.21 mg/kg | ICP-MS |
| Heavy Metals (As) | ≤ 1.0 mg/kg | 0.08 mg/kg | ICP-MS |
| Heavy Metals (Hg) | ≤ 0.1 mg/kg | < 0.01 mg/kg | ICP-MS |
| Heavy Metals (Cd) | ≤ 0.5 mg/kg | 0.04 mg/kg | ICP-MS |
| Residual n-Hexane | ≤ 1.0 mg/kg | < 0.5 mg/kg | GC |
| Residual Ethanol | ≤ 50 mg/kg | 12 mg/kg | GC |
| Total Plate Count | ≤ 1,000 CFU/g | 280 CFU/g | AOAC 966.23 |
| Mold & Yeast | ≤ 100 CFU/g | < 10 CFU/g | AOAC 997.02 |
| E. coli | Absent/25g | Absent | AOAC 998.09 |
| Salmonella | Absent/25g | Absent | AOAC 998.09 |
Meso-Zeaxanthin has an absorption maximum at approximately 460 nm — precisely matched to the peak wavelength of high-energy blue light emitted by LED screens, smartphones, and sunlight. By absorbing these photons before they reach the photoreceptor outer segments, Meso-Zeaxanthin prevents photochemical damage to the retina.
Mechanism of Action:
The conjugated polyene chain of Meso-Zeaxanthin (11 conjugated double bonds) absorbs blue light photons and dissipates the energy as harmless heat
This photoprotective effect reduces lipofuscin accumulation in the RPE — a hallmark of retinal aging
The spatial distribution of MZ at the foveal center ensures maximum protection at the point of highest visual acuity
Why It Matters: The average adult now spends 7+ hours per day looking at digital screens. Children, whose ocular media are more transparent to blue light, are exposed as early as age 2. Supplementing with Meso-Zeaxanthin helps maintain the macular pigment's natural blue-light-filtering capacity.
Mechanism of Action:
Meso-Zeaxanthin quenches singlet oxygen (¹O₂) — a highly reactive oxygen species generated in the retina by the combination of light, oxygen, and photosensitizers — with an efficiency comparable to or exceeding that of lutein
It scavenges lipid peroxyl radicals in photoreceptor outer segment membranes, which are rich in polyunsaturated fatty acids (especially DHA) and extremely vulnerable to peroxidation
Meso-Zeaxanthin stabilizes photoreceptor membrane integrity by intercalating perpendicular to the lipid bilayer, providing structural as well as chemical protection
Key Reference: Widomska J, et al. "Can xanthophylls protect the retina from light-induced damage?" Arch Biochem Biophys. 2020;695:108583.
AMD is the leading cause of irreversible vision loss in adults over 50, affecting approximately 196 million people worldwide (projected to reach 288 million by 2040). Meso-Zeaxanthin supplementation directly addresses the underlying pathology.
Mechanism of Action:
Increases Macular Pigment Optical Density (MPOD) — a validated biomarker inversely correlated with AMD risk
Reduces oxidative stress in the RPE, slowing drusen formation (the hallmark deposit of early AMD)
Protects against choroidal neovascularization (wet AMD) by reducing VEGF (vascular endothelial growth factor) expression
Preserves photoreceptor survival by maintaining mitochondrial function in retinal cells
Key Clinical Evidence — AREDS2:The Age-Related Eye Disease Study 2 (AREDS2) — one of the largest and most influential eye health trials ever conducted (n=4,203, multicenter, randomized, double-blind, placebo-controlled) — demonstrated that supplementation with lutein (10 mg) and zeaxanthin (2 mg) reduced the risk of progression to advanced AMD by 18% compared to the original AREDS formula (which contained beta-carotene). AREDS2 established lutein and zeaxanthin as the preferred carotenoids for AMD prevention, replacing beta-carotene due to its association with increased lung cancer risk in smokers.
Importantly, while AREDS2 used only lutein and zeaxanthin, subsequent research has shown that including Meso-Zeaxanthin in the formulation — to match the eye's natural macular pigment composition — may provide superior MPOD enhancement.
Key Clinical Evidence — MacuHealth Trial:A 2017 randomized controlled trial (n=108) demonstrated that supplementation with the 10:10:2 formula (10 mg lutein, 10 mg Meso-Zeaxanthin, 2 mg zeaxanthin) — the exact ratio found in the human macula — significantly increased MPOD across all retinal eccentricities. The Meso-Zeaxanthin-containing formula outperformed lutein-only and lutein-plus-zeaxanthin formulations for central foveal pigment enhancement (Akuffo et al., 2017).
Beyond disease prevention, Meso-Zeaxanthin improves visual function in healthy individuals:
Mechanism of Action:
Glare recovery: Reduces photostress recovery time — the time needed to regain functional vision after exposure to bright light (e.g., oncoming headlights at night)
Contrast sensitivity: Improves the ability to distinguish objects from their background, especially in low-light conditions
Visual processing speed: Enhances neural processing speed in the visual cortex — important for activities like driving and sports
Reduces chromatic aberration: Filters short-wavelength light that is poorly focused by the eye's optics, improving visual acuity
Key Clinical Evidence:
A 2018 randomized trial in Nutrients (n=105) demonstrated that 12 months of macular carotenoid supplementation with Meso-Zeaxanthin significantly improved contrast sensitivity, glare disability, and photostress recovery time in healthy young adults (Stringham et al., 2018)
Emerging research reveals that lutein and its isomer Meso-Zeaxanthin are the predominant carotenoids in the human brain, accounting for 66–77% of total brain carotenoid concentrations. Brain concentrations correlate strongly with macular pigment levels — making MPOD a non-invasive window into brain carotenoid status.
Mechanism of Action:
Meso-Zeaxanthin and lutein support neural efficiency — the brain's ability to perform tasks with minimal energy expenditure
They enhance inter-neural communication and white matter integrity
They protect against oxidative stress in brain tissue, which is particularly vulnerable due to its high oxygen consumption and lipid-rich composition
Key Clinical Evidence:
A 2020 randomized clinical trial in JAMA Ophthalmology (n=60) found that 12 months of lutein, zeaxanthin, and Meso-Zeaxanthin supplementation significantly improved cognitive function scores in community-dwelling older adults, including measures of complex attention, cognitive flexibility, and executive function (Nolan et al., 2020)
The gold standard formulation is the macular pigment ratio:
| Formulation | Lutein | Meso-Zeaxanthin | Zeaxanthin | Application |
|---|---|---|---|---|
| Macular Pigment Formula (10:10:2) | 10 mg | 10 mg | 2 mg | Daily eye health; AMD prevention |
| Standard Eye Health | 10 mg | 5 mg | 2 mg | General eye health maintenance |
| High-Potency Eye Formula | 20 mg | 10 mg | 4 mg | AMD patients; high-risk individuals |
| Brain & Eye Combo | 10 mg | 10 mg | 2 mg | Cognitive + visual performance |
Recommended Daily Dose: 10 mg Meso-Zeaxanthin (as part of the 10:10:2 formula)
Formulation Forms:
Softgels — Use oil suspension (5–10% MZ in MCT/sunflower oil); superior bioavailability (carotenoids are fat-soluble)
Hard capsules — Use microencapsulated powder (5–10%); better stability in dry form
Tablets — Use microencapsulated powder with appropriate excipients; consider enteric coating to protect from gastric acid
Gummies — Use water-dispersible form; challenging due to light sensitivity
| Application | Typical Usage Rate | Considerations |
|---|---|---|
| Eye health beverages | 2–5 mg MZ/serving | Use water-dispersible form; opaque packaging essential; pH 3.5–7.0 |
| Fortified dairy products | 2–5 mg MZ/serving | Excellent fat matrix for bioavailability; light-protective packaging |
| Nutrition bars | 5–10 mg MZ/bar | Add post-baking; incorporate with fat source |
| RTD protein shakes | 2–5 mg MZ/serving | Water-dispersible form; protect from light |
Meso-Zeaxanthin is increasingly incorporated into medical food formulations for:
AMD patients — Slowing disease progression per AREDS2 evidence
Diabetic retinopathy — Emerging research on retinal protection
Glaucoma — Neuroprotective potential for retinal ganglion cells
Post-cataract surgery recovery — Supporting retinal health after lens replacement
| Application | Usage Rate | Benefit Claim |
|---|---|---|
| Eye contour serums | 0.1–0.5% | Antioxidant protection for delicate periorbital skin |
| Anti-blue-light skincare | 0.1–0.3% | Absorbs blue light; prevents photoaging |
| Sun protection boosters | 0.05–0.2% | Synergistic with UV filters |
Meso-Zeaxanthin is a high-value, technically complex ingredient. Selecting the right supplier requires careful due diligence.
The most critical quality check. Due to its high cost, Meso-Zeaxanthin is susceptible to adulteration — usually by substituting cheaper lutein or zeaxanthin.
What to demand:
✓ HPLC chromatogram showing three distinct, well-resolved peaks: lutein, zeaxanthin, and Meso-Zeaxanthin
✓ Chiral HPLC confirming the (3R,3'S) stereochemistry — authentic Meso-Zeaxanthin
✓ Cis-isomer content ≤ 5% — higher levels indicate poor processing or degradation
✓ Process description — reputable suppliers will explain their production method (typically acid-catalyzed isomerization of lutein)
Meso-Zeaxanthin is produced by isomerizing lutein — a delicate chemical process:
| Technology | Advantages | Disadvantages |
|---|---|---|
| Acid-catalyzed isomerization (commercial standard) | Proven, scalable, cost-effective | Requires careful purification to remove cis-isomers and residual catalysts |
| Enzymatic conversion (emerging) | High selectivity, mild conditions, fewer byproducts | Higher cost, limited scalability currently |
| Microbial fermentation (future) | Direct biosynthesis, sustainable | Still in research phase |
Key questions to ask:
What is your conversion efficiency (lutein → Meso-Zeaxanthin)?
How do you separate MZ from unreacted lutein and zeaxanthin?
What is your cis-isomer specification?
How do you control residual solvents and heavy metals?
Carotenoids are inherently unstable — sensitive to light, heat, oxygen, and acid. A quality supplier should provide:
✓ Accelerated stability data (40°C/75% RH, 6 months)
✓ Long-term stability data (25°C/60% RH, 24 months)
✓ Forced degradation data (photostability, oxidative stability)
✓ Formulation compatibility guidance — which excipients to use or avoid
| Certification | Importance |
|---|---|
| ISO 22000 / BRCGS / FSSC 22000 | Essential — food safety management system |
| GMP | Essential — verified manufacturing practices |
| FDA Registration | Required for US market access |
| Novel Food (EU) Compliance | Required for EU market access |
| Non-GMO | Strongly preferred for natural products |
| Kosher / Halal | Expands market access |
| Gluten-Free | Important for allergen-sensitive consumers |
Industry experience: 15+ years in carotenoid chemistry
IP position: Owns or licenses relevant patents for Meso-Zeaxanthin production
Regulatory history: No FDA warning letters or import alerts
Client references: Who else uses their Meso-Zeaxanthin?
Audit history: Willing to share recent third-party audit reports
With over 20 years of specialized experience in plant extraction and carotenoid chemistry, GreenskyBio is uniquely positioned to supply high-quality Meso-Zeaxanthin for eye health formulations.
Why Choose GreenskyBio for Meso-Zeaxanthin?
| Advantage | Description |
|---|---|
| Carotenoid Expertise | Deep technical knowledge in lutein extraction (from marigold), isomerization chemistry, and carotenoid purification |
| Verified Purity | HPLC-verified Meso-Zeaxanthin content with stereochemical confirmation — not just "total carotenoids" claims |
| Low Cis-Isomers | Purification process ensures ≤ 5% cis-isomers, maximizing bioactivity |
| Multiple Forms | Oil suspension, microencapsulated powder, and water-dispersible forms — all optimized for stability |
| GMP Manufacturing | ISO 22000, BRCGS, and SGS-GMP certified facilities |
| Oxidation Control | Comprehensive oxidation monitoring (PV, AV, TOTOX) on every batch |
| Certifications | Non-GMO, Kosher, Halal, Gluten-Free |
| Flexible Supply | Sample: 1g |
| Global Export | $30M+ annual export to 40+ countries |
Our Quality Promise:Every batch of GreenskyBio Meso-Zeaxanthin is tested for:
✓ Meso-Zeaxanthin content (HPLC-UV, 450 nm)
✓ Total carotenoids (spectrophotometry)
✓ Cis-isomer content (HPLC)
✓ Lutein and zeaxanthin residual (HPLC)
✓ Heavy metals (Pb, As, Hg, Cd by ICP-MS)
✓ Solvent residues (GC, ICH Q3C compliant)
✓ Oxidation markers (Peroxide Value, Anisidine Value, TOTOX)
✓ Microbiology (full panel)
Customization Options:
Custom lutein:Meso-Zeaxanthin:zeaxanthin ratios
Bespoke oil suspension formulations (MCT, sunflower, or olive oil)
Microencapsulation with choice of carrier (modified starch, gum arabic, gelatin)
Water-dispersible grades for beverage applications
Combined formulas with complementary eye health ingredients (Astaxanthin, Bilberry Extract, zinc, vitamin C/E)
Meso-Zeaxanthin is not just another eye health ingredient — it is the dominant carotenoid at the foveal center, the precise point responsible for the sharp vision you use to read these words, recognize faces, and navigate the world. As the global population ages and screen time continues to climb, the need for comprehensive macular pigment support — including all three macular carotenoids — has never been greater.
The 10:10:2 formula (lutein 10 mg, Meso-Zeaxanthin 10 mg, zeaxanthin 2 mg) represents the current gold standard in eye health supplementation, matching the natural composition of the human macula and supported by a growing body of clinical evidence.
Partner with GreenskyBio for your Meso-Zeaxanthin needs:
Email sales@greenskybio.com for a quote and free sample
Request a full COA, HPLC chromatogram, and specification sheet
Evaluate our quality — request a 1g sample for your own analytical testing
Speak with our carotenoid technical team about custom formulations, the 10:10:2 ratio, or stability optimization
Protect the world's vision — one capsule at a time. Partner with GreenskyBio.
AREDS2 Research Group. "Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial." JAMA. 2013;309(19):2005-2015.
Akuffo KO, et al. "The impact of supplementation with lutein, zeaxanthin, and meso-zeaxanthin on macular pigment optical density: a systematic review and meta-analysis." Nutrients. 2017;9(11):1172.
Nolan JM, et al. "The impact of supplemental macular carotenoids on cognitive function in older adults: a randomized clinical trial." JAMA Ophthalmol. 2020;138(5):501-510.
Stringham JM, et al. "Macular carotenoid supplementation improves visual performance, sleep quality, and adverse physical symptoms in those with high screen time exposure." Nutrients. 2018;10(8):1009.
Bernstein PS, et al. "Lutein, zeaxanthin, and meso-zeaxanthin: the basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease." Prog Retin Eye Res. 2016;50:34-66.
Widomska J, et al. "Can xanthophylls protect the retina from light-induced damage?" Arch Biochem Biophys. 2020;695:108583.
Hammond BR, et al. "The influence of macular carotenoids on visual and cognitive function." Annu Rev Nutr. 2020;40:223-245.
2026-07-17
2026-07-17
2026-07-17
2026-07-17
2026-07-17
2026-07-17
2026-07-17
2026-07-17
2026-07-17
2026-07-17